PCN294 DERIVATION OF UTILITY VALUES FOR PATIENTS WITH ADVANCED HEPATOCELULAR CARCINOMA BASED ON HRQOL DATA FROM THE PHASE 3 CELESTIAL TRIAL
May 1, 2019, 00:00
10.1016/j.jval.2019.04.413
https://www.valueinhealthjournal.com/article/S1098-3015(19)30605-9/fulltext
Title :
PCN294 DERIVATION OF UTILITY VALUES FOR PATIENTS WITH ADVANCED HEPATOCELULAR CARCINOMA BASED ON HRQOL DATA FROM THE PHASE 3 CELESTIAL TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30605-9&doi=10.1016/j.jval.2019.04.413
First page :
Section Title :
Open access? :
No
Section Order :
10059